rs35732567

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369.3(DNAH5):​c.7609+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 1,549,262 control chromosomes in the GnomAD database, including 117,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11042 hom., cov: 32)
Exomes 𝑓: 0.39 ( 106521 hom. )

Consequence

DNAH5
NM_001369.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0950

Publications

5 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-13810040-G-A is Benign according to our data. Variant chr5-13810040-G-A is described in ClinVar as Benign. ClinVar VariationId is 197516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH5NM_001369.3 linkc.7609+19C>T intron_variant Intron 45 of 78 ENST00000265104.5 NP_001360.1 Q8TE73

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkc.7609+19C>T intron_variant Intron 45 of 78 1 NM_001369.3 ENSP00000265104.4 Q8TE73
DNAH5ENST00000681290.1 linkc.7564+19C>T intron_variant Intron 45 of 78 ENSP00000505288.1 A0A7P0Z455
DNAH5ENST00000512443.1 linkn.465+19C>T intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.377
AC:
57223
AN:
151922
Hom.:
11038
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.325
Gnomad AMI
AF:
0.524
Gnomad AMR
AF:
0.399
Gnomad ASJ
AF:
0.367
Gnomad EAS
AF:
0.625
Gnomad SAS
AF:
0.345
Gnomad FIN
AF:
0.353
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.388
Gnomad OTH
AF:
0.393
GnomAD2 exomes
AF:
0.393
AC:
60520
AN:
154048
AF XY:
0.390
show subpopulations
Gnomad AFR exome
AF:
0.323
Gnomad AMR exome
AF:
0.399
Gnomad ASJ exome
AF:
0.356
Gnomad EAS exome
AF:
0.646
Gnomad FIN exome
AF:
0.362
Gnomad NFE exome
AF:
0.384
Gnomad OTH exome
AF:
0.406
GnomAD4 exome
AF:
0.388
AC:
542739
AN:
1397226
Hom.:
106521
Cov.:
35
AF XY:
0.387
AC XY:
266642
AN XY:
689292
show subpopulations
African (AFR)
AF:
0.327
AC:
10313
AN:
31578
American (AMR)
AF:
0.406
AC:
14558
AN:
35844
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
9041
AN:
25154
East Asian (EAS)
AF:
0.573
AC:
20544
AN:
35856
South Asian (SAS)
AF:
0.342
AC:
27066
AN:
79204
European-Finnish (FIN)
AF:
0.362
AC:
17781
AN:
49160
Middle Eastern (MID)
AF:
0.364
AC:
1481
AN:
4068
European-Non Finnish (NFE)
AF:
0.389
AC:
419427
AN:
1078568
Other (OTH)
AF:
0.390
AC:
22528
AN:
57794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
16852
33705
50557
67410
84262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13296
26592
39888
53184
66480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.377
AC:
57252
AN:
152036
Hom.:
11042
Cov.:
32
AF XY:
0.376
AC XY:
27921
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.325
AC:
13490
AN:
41478
American (AMR)
AF:
0.399
AC:
6101
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.367
AC:
1272
AN:
3470
East Asian (EAS)
AF:
0.625
AC:
3224
AN:
5162
South Asian (SAS)
AF:
0.345
AC:
1659
AN:
4812
European-Finnish (FIN)
AF:
0.353
AC:
3729
AN:
10576
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.388
AC:
26371
AN:
67940
Other (OTH)
AF:
0.389
AC:
820
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1844
3688
5533
7377
9221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.378
Hom.:
3763
Bravo
AF:
0.381
Asia WGS
AF:
0.450
AC:
1562
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 16, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 3 Benign:1
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.3
DANN
Benign
0.76
PhyloP100
0.095
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35732567; hg19: chr5-13810149; API